Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS

Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS

Abstract Rationale Early corticosteroid treatment is used to treat COVID-19-related acute respiratory distress syndrome (ARDS). Infection is a well-documented adverse effect of corticosteroid therapy. Objectives To determine whether early corticosteroid therapy to treat COVID-19 ARDS was associated...

Full description

Bibliographic Details
Main Authors: Pauline Lamouche-Wilquin, Jérôme Souchard, Morgane Pere, Matthieu Raymond, Pierre Asfar, Cédric Darreau, Florian Reizine, Baptiste Hourmant, Gwenhaël Colin, Guillaume Rieul, Pierre Kergoat, Aurélien Frérou, Julien Lorber, Johann Auchabie, Béatrice La Combe, Philippe Seguin, Pierre-Yves Egreteau, Jean Morin, Yannick Fedun, Emmanuel Canet, Jean-Baptiste Lascarrou, Agathe Delbove
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Critical Care
Subjects:
Mechanical ventilation
SARS-CoV-19
Nosocomial pneumonia
Dexamethasone
Methylprednisolone
Online Access:https://doi.org/10.1186/s13054-022-04097-8

Internet

https://doi.org/10.1186/s13054-022-04097-8

Similar Items